Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis

Pei Wu,1 Pengliang Wang,1 Bin Ma,2 Songcheng Yin,1 Yuen Tan,1 Wenbin Hou,1 Zhenning Wang,1 Huimian Xu,1 Zhi Zhu1 1Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang 110001, China; 2Department of Colorectal Surgery, Cancer Hospital of China Medical Univer...

Full description

Bibliographic Details
Main Authors: Wu P, Wang PL, Ma B, Yin SC, Tan YE, Hou WB, Wang ZN, Xu HM, Zhu Z
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/palliative-gastrectomy-plus-chemotherapy-versus-chemotherapy-alone-for-peer-reviewed-article-CMAR
_version_ 1828541598571429888
author Wu P
Wang PL
Ma B
Yin SC
Tan YE
Hou WB
Wang ZN
Xu HM
Zhu Z
author_facet Wu P
Wang PL
Ma B
Yin SC
Tan YE
Hou WB
Wang ZN
Xu HM
Zhu Z
author_sort Wu P
collection DOAJ
description Pei Wu,1 Pengliang Wang,1 Bin Ma,2 Songcheng Yin,1 Yuen Tan,1 Wenbin Hou,1 Zhenning Wang,1 Huimian Xu,1 Zhi Zhu1 1Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang 110001, China; 2Department of Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Dadong District, Shenyang 110042, Liaoning Province, China Background: Whether palliative gastrectomy combined with chemotherapy can improve the survival of patients with advanced gastric cancer remains controversial. We performed a meta-analysis to clarify whether palliative gastrectomy plus chemotherapy can benefit patients with incurable advanced gastric cancer and to explore the best candidates in this patient population. Methods: We searched the literature systematically using electronic databases including PubMed, EMBASE, and the Cochrane Library. And HRs and their 95% CIs were used to express the results for overall survival (OS) and progression-free survival (PFS). Results: One randomized controlled trial with 175 patients and 12 cohort studies with 2,193 patients were analyzed. The pooled HR for OS (HR=0.43, 95% CI=0.29–0.65, P<0.001), ­subgroup analysis of stage M1 (HR=0.53, 95% CI=0.40–0.72, P<0.001), peritoneal dissemination (HR=0.46, 95% CI=0.28–0.73, P=0.001), and liver metastasis (HR=0.46, 95% CI=0.33–0.65, P<0.001) all indicated the superiority of palliative gastrectomy plus chemotherapy. However, the pooled HR for PFS (HR=0.61, 95% CI=0.33–1.13, P=0.110) got separate outcome. Conclusion: The results of this meta-analysis indicated that palliative gastrectomy plus chemotherapy can improve OS for incurable advanced gastric cancer. In addition, analyses based on liver metastasis and peritoneal dissemination demonstrated the advantages of palliative gastrectomy plus chemotherapy. However, the PFS of incurable advanced gastric cancer with palliative gastrectomy plus chemotherapy was no better than that under chemotherapy alone. Keywords: advanced gastric cancer, palliative gastrectomy, chemotherapy, survival
first_indexed 2024-12-12T01:42:15Z
format Article
id doaj.art-82772fa38c244bce9a6f093ac5869140
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-12T01:42:15Z
publishDate 2018-10-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-82772fa38c244bce9a6f093ac58691402022-12-22T00:42:40ZengDove Medical PressCancer Management and Research1179-13222018-10-01Volume 104759477141783Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysisWu PWang PLMa BYin SCTan YEHou WBWang ZNXu HMZhu ZPei Wu,1 Pengliang Wang,1 Bin Ma,2 Songcheng Yin,1 Yuen Tan,1 Wenbin Hou,1 Zhenning Wang,1 Huimian Xu,1 Zhi Zhu1 1Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang 110001, China; 2Department of Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Dadong District, Shenyang 110042, Liaoning Province, China Background: Whether palliative gastrectomy combined with chemotherapy can improve the survival of patients with advanced gastric cancer remains controversial. We performed a meta-analysis to clarify whether palliative gastrectomy plus chemotherapy can benefit patients with incurable advanced gastric cancer and to explore the best candidates in this patient population. Methods: We searched the literature systematically using electronic databases including PubMed, EMBASE, and the Cochrane Library. And HRs and their 95% CIs were used to express the results for overall survival (OS) and progression-free survival (PFS). Results: One randomized controlled trial with 175 patients and 12 cohort studies with 2,193 patients were analyzed. The pooled HR for OS (HR=0.43, 95% CI=0.29–0.65, P<0.001), ­subgroup analysis of stage M1 (HR=0.53, 95% CI=0.40–0.72, P<0.001), peritoneal dissemination (HR=0.46, 95% CI=0.28–0.73, P=0.001), and liver metastasis (HR=0.46, 95% CI=0.33–0.65, P<0.001) all indicated the superiority of palliative gastrectomy plus chemotherapy. However, the pooled HR for PFS (HR=0.61, 95% CI=0.33–1.13, P=0.110) got separate outcome. Conclusion: The results of this meta-analysis indicated that palliative gastrectomy plus chemotherapy can improve OS for incurable advanced gastric cancer. In addition, analyses based on liver metastasis and peritoneal dissemination demonstrated the advantages of palliative gastrectomy plus chemotherapy. However, the PFS of incurable advanced gastric cancer with palliative gastrectomy plus chemotherapy was no better than that under chemotherapy alone. Keywords: advanced gastric cancer, palliative gastrectomy, chemotherapy, survivalhttps://www.dovepress.com/palliative-gastrectomy-plus-chemotherapy-versus-chemotherapy-alone-for-peer-reviewed-article-CMARadvanced gastric cancerpalliative gastrectomychemotherapysurvival
spellingShingle Wu P
Wang PL
Ma B
Yin SC
Tan YE
Hou WB
Wang ZN
Xu HM
Zhu Z
Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
Cancer Management and Research
advanced gastric cancer
palliative gastrectomy
chemotherapy
survival
title Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
title_full Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
title_fullStr Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
title_full_unstemmed Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
title_short Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
title_sort palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer a meta analysis
topic advanced gastric cancer
palliative gastrectomy
chemotherapy
survival
url https://www.dovepress.com/palliative-gastrectomy-plus-chemotherapy-versus-chemotherapy-alone-for-peer-reviewed-article-CMAR
work_keys_str_mv AT wup palliativegastrectomypluschemotherapyversuschemotherapyaloneforincurableadvancedgastriccancerametaanalysis
AT wangpl palliativegastrectomypluschemotherapyversuschemotherapyaloneforincurableadvancedgastriccancerametaanalysis
AT mab palliativegastrectomypluschemotherapyversuschemotherapyaloneforincurableadvancedgastriccancerametaanalysis
AT yinsc palliativegastrectomypluschemotherapyversuschemotherapyaloneforincurableadvancedgastriccancerametaanalysis
AT tanye palliativegastrectomypluschemotherapyversuschemotherapyaloneforincurableadvancedgastriccancerametaanalysis
AT houwb palliativegastrectomypluschemotherapyversuschemotherapyaloneforincurableadvancedgastriccancerametaanalysis
AT wangzn palliativegastrectomypluschemotherapyversuschemotherapyaloneforincurableadvancedgastriccancerametaanalysis
AT xuhm palliativegastrectomypluschemotherapyversuschemotherapyaloneforincurableadvancedgastriccancerametaanalysis
AT zhuz palliativegastrectomypluschemotherapyversuschemotherapyaloneforincurableadvancedgastriccancerametaanalysis